Laboratoires Thea
Clinical trials sponsored by Laboratoires Thea, explained in plain language.
-
New eye drop shows promise in glaucoma battle
Disease control CompletedThis study tested two different strengths of a new eye drop called T4090 against an existing drop, Rhopressa, in 161 adults with open-angle glaucoma or high eye pressure. The goal was to see which one lowers eye pressure better and is safer. Participants used the drops for a set …
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New eye drops bring relief to dry eye sufferers
Symptom relief CompletedThis study tested a new preservative-free eye drop (Thealoz Total) in 30 adults with chronic dry eye disease and eye surface inflammation. Participants used the drops daily for 12 weeks. The goal was to see if the drops reduce eye redness and improve symptoms like dryness and dis…
Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated May 26, 2026 07:51 UTC
-
New eye drop T2769 takes on Hylo-Forte in dry eye showdown
Symptom relief CompletedThis study tested whether a new eye drop, T2769, works as well as the existing drop Hylo-Forte for people with moderate to severe dry eye. 74 adults who still had dry eye symptoms despite using artificial tears took part. The main goal was to see if T2769 could reduce eye surface…
Phase: NA • Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated May 26, 2026 07:24 UTC
-
New eye drop T2769 matches leading dry eye treatment in study
Symptom relief CompletedThis study tested whether a new eye drop, T2769, works as well as a standard treatment (Vismed Multi) for moderate to severe dry eye. 251 adults used the drops for 35 days. The main goal was to see if T2769 could reduce eye surface damage as effectively as Vismed, while also chec…
Phase: NA • Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated May 05, 2026 11:56 UTC